RXSIGHT Trademark

Trademark Overview

On Friday, March 25, 2016, a trademark application was filed for RXSIGHT with the United States Patent and Trademark Office. The USPTO has given the RXSIGHT trademark a serial number of 86984502. The federal status of this trademark filing is REGISTERED as of Tuesday, November 5, 2019. This trademark is owned by Calhoun Vision. The RXSIGHT trademark is filed in the Medical Instrument Products and Computer & Software Services & Scientific Services categories with the following description:

Intra-ocular lenses; Intraocular lens biometers; Intraocular lenses; Lenses for surgical implantation; Prosthetic intraocular implants

Conducting research and clinical trials for others relating to medical devices and pharmaceuticals in the field of ophthalmology
rxsight

General Information

Serial Number86984502
Word MarkRXSIGHT
Filing DateFriday, March 25, 2016
Status700 - REGISTERED
Status DateTuesday, November 5, 2019
Registration Number5903509
Registration DateTuesday, November 5, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 7, 2017

Trademark Statements

Pseudo MarkRX SIGHT
Goods and ServicesIntra-ocular lenses; Intraocular lens biometers; Intraocular lenses; Lenses for surgical implantation; Prosthetic intraocular implants
Goods and ServicesConducting research and clinical trials for others relating to medical devices and pharmaceuticals in the field of ophthalmology

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, March 30, 2016
Primary Code010
First Use Anywhere DateFriday, May 31, 2019
First Use In Commerce DateFriday, May 31, 2019
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, March 30, 2016
Primary Code042
First Use Anywhere DateTuesday, July 31, 2018
First Use In Commerce DateTuesday, July 31, 2018

Trademark Owner History

Party NameRXSIGHT, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressALISA VIEJO, CA 92656
Party NameRXSIGHT, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressALISO VIEJO, CA 92656
Party NameRXSIGHT, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressALISO VIEJO, CA 92656
Party NameRXSIGHT, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressALISO VIEJO, CA 92656
Party NameCalhoun Vision
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPasadena, CA 91107

Trademark Events

Event DateEvent Description
Tuesday, March 29, 2016NEW APPLICATION ENTERED
Wednesday, March 30, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 31, 2016NOTICE OF PSEUDO MARK E-MAILED
Friday, July 8, 2016ASSIGNED TO EXAMINER
Monday, July 11, 2016NON-FINAL ACTION WRITTEN
Monday, July 11, 2016NON-FINAL ACTION E-MAILED
Monday, July 11, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, December 2, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, December 2, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, December 16, 2016TEAS VOLUNTARY AMENDMENT RECEIVED
Tuesday, January 10, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 10, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 11, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 25, 2017AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, January 27, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 15, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 7, 2017PUBLISHED FOR OPPOSITION
Tuesday, March 7, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 2, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 31, 2017SOU TEAS EXTENSION RECEIVED
Tuesday, October 31, 2017SOU EXTENSION 1 FILED
Tuesday, October 31, 2017SOU EXTENSION 1 GRANTED
Thursday, November 2, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 19, 2018SOU TEAS EXTENSION RECEIVED
Thursday, April 19, 2018SOU EXTENSION 2 FILED
Thursday, April 19, 2018SOU EXTENSION 2 GRANTED
Saturday, April 21, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 23, 2018SOU TEAS EXTENSION RECEIVED
Tuesday, October 23, 2018SOU EXTENSION 3 FILED
Tuesday, October 23, 2018SOU EXTENSION 3 GRANTED
Thursday, October 25, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 24, 2019SOU TEAS EXTENSION RECEIVED
Wednesday, April 24, 2019SOU EXTENSION 4 FILED
Wednesday, April 24, 2019SOU EXTENSION 4 GRANTED
Friday, April 26, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 16, 2019TEAS STATEMENT OF USE RECEIVED
Monday, September 16, 2019SOU TEAS EXTENSION RECEIVED
Monday, September 30, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, September 16, 2019SOU EXTENSION 5 FILED
Monday, September 30, 2019SOU EXTENSION 5 GRANTED
Monday, September 16, 2019TEAS REQUEST TO DIVIDE RECEIVED
Monday, September 16, 2019DIVISIONAL REQUEST RECEIVED
Monday, September 30, 2019DIVISIONAL PROCESSING COMPLETE
Monday, September 16, 2019USE AMENDMENT FILED
Monday, September 30, 2019STATEMENT OF USE PROCESSING COMPLETE
Monday, September 30, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, October 1, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, October 1, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 5, 2019REGISTERED-PRINCIPAL REGISTER
Wednesday, January 19, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, November 5, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, November 5, 2025TEAS SECTION 8 & 15 RECEIVED

Related Keywords

rxsight intraocular lenses relating others trials medical pharmaceuticals ophthalmology field clinical